Phaos Technology Holdings (Cayman) (POAS) Cash & Current Investments (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Cash & Current Investments of $54989.0 for Q4 2025, down 43.26% on a QoQ basis from $96918.3 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Cash & Current Investments (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Cash & Current Investments history runs 2 years deep, the most recent figure standing at $54989.0 for Q4 2025.
- Quarterly Cash & Current Investments changed N/A year-over-year to $54989.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $54989.0 (changed N/A YoY) and the FY2025 annual result came in at $97007.0, down 94.35% from the prior year.
- Cash & Current Investments was $54989.0 for Q4 2025 at Phaos Technology Holdings (Cayman), down from $96918.3 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $1.7 million in Q2 2024 and bottomed at $54989.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.05 Mn | 5.99 Mn | - | 54,989.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 54,989.00 |
| Apr 30, 2025 | 96,918.26 |
| Apr 30, 2024 | 1.72 Mn |